Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles. Chittasupho C*, Lirdprapamongkol K, Kewsuwan P, Sarisuta N. Eur J Pharm Biopharm. 2014 Oct;88(2):529-38.
Chittasupho C*, Lirdprapamongkol K, Kewsuwan P, Sarisuta N.
Eur J Pharm Biopharm. 2014 Oct;88(2):529-38.
Related Posts
28 Dec 2010
ChpR is a chlorpyrifos-responsive transcription regulator in Sinorhizobium meliloti. Whangsuk W, Dubbs JM, Sallabhan R, Somsongkul K, Mongkolsuk S, Loprasert S J Mol Microbiol Biotechnol18p141-7(2010)
View More
01 Oct 2014
Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles. Chittasupho C*,LirdprapamongkolK, Kewsuwan P, Sarisuta N. Eur J Pharm Biopharm. 2014 Oct;88(2):529-38.
View More
Recent Posts
24 Jun 2024
Breast cancer prevention by dietary polyphenols: Microemulsion formulation and in vitro Studies Cristy GP, Liana D, Chatwichien J, Aonbangkhen C, Srisomsap C, Phanumartwiwath A Sci Pharm. 2024;9(2):25.
View More
